Articles

CCB stock results show that Coastal Finl missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. More

Because it costs virtually nothing to invest these days, buy these 3 stocks now for $500 as it is easier than ever. More

DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze. More

The med tech stocks are worth checking out for value investors seeking potentially overlooked growth catalysts. More

These undervalued stocks blend growth and value alongside imminent bullish tendencies that could push per-share pricing sky-high. More

RIvian is gearing up to report earnings on May 7. Here's why, despite its problems, RIVN stock is still a good buy ahead of earnings. More

With Americans' average real wages rising, many guilty pleasure stocks can easily outperform going forward. More

Subscriber Sign in